040 From the Conference Floor: The Latest Advances in Myeloma Care
This episode explores the latest breakthroughs from the world's leading myeloma conferences, explaining how new research and clinical trials could shape future treatment and improve patient care with ...
30 Heinä 41min
039 DT-PACE Explained: When Myeloma Needs a Different Approach
This episode explains when DT-PACE chemotherapy is used in myeloma, how it works, what patients can expect during treatment, and why it remains an important bridge to newer therapies.📌Key Takeaways: ...
14 Heinä 23min
038 A New Four-Drug Treatment for Myeloma: What Does DVRD Mean for Patients?
Experts discuss the approval of the new DVRD four-drug treatment for newly diagnosed myeloma patients who are not eligible for a stem cell transplant, exploring its benefits, risks and how treatment d...
25 Kesä 35min
037 From Patient to Author: Jonathan Gluck’s Myeloma Story
Author Jonathan Gluck shares his deeply personal experience of living with myeloma, reflecting on diagnosis, uncertainty, treatment, resilience and what it means to build a life alongside cancer.📌Key...
11 Kesä 48min
036 Infection and Myeloma - Staying Safe Without Stopping Life
This episode explores why people with myeloma are more vulnerable to infection, how treatments affect immunity, and the practical steps patients and carers can take to stay well.📌Key Takeaways:Myelom...
29 Touko 41min
035 Blood Clots and Myeloma - What Every Patient Should Know
This episode explains why people with myeloma are at higher risk of blood clots, how blood thinners help, and the warning signs patients and carers should never ignore. 📌Key Takeaways: Myeloma and s...
14 Touko 27min
034 Pain in Myeloma - Understanding It and Taking Back Control
This episode explores why pain happens in myeloma, how it affects daily life, and the many ways it can be managed - from painkillers to specialist support. 📌Key Takeaways: Myeloma pain is common - b...
1 Touko 38min
033 MRD Explained: How Much Myeloma Is Really Left
This episode explains minimal residual disease (MRD) - what it is, how it’s measured, and how it could shape more personalised myeloma treatment in the future. 📌Key Takeaways: Even when blood tests ...
9 Huhti 29min
